Gilead Sciences, Inc.

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0000882095

Type: FundHoldings: 14Value: $1.2BLatest: 2025Q1

GILEAD SCIENCES, INC. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 14 holdings worth $1.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "GLPG",
  "ALLO",
  "RCUS",
  "TNGX",
  "ASMB",
  "LPTX",
  "KYTX",
  "BRNS",
  "ACLX",
  "IKNA",
  "HOOK",
  "KLRS",
  "XLO"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-13
Total Holdings: 14
Total Value: 1181331731
Accession Number: 0001123292-25-000217
Form Type: 13F-HR
CIK: gilead-sciences
Manager Name: Gilead-Sciences

Data Enrichment

100% identified

14 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

14 positions • $1.2B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Arcellx, Inc.

ACLX|03940C100

Shares:6.7M

Value:$440.9M

% of Portfolio:37.3% ($440.9M/$1.2B)

GALAPAGOS NV

GLPG|36315X101

Shares:16.7M

Value:$419.4M

% of Portfolio:35.5% ($419.4M/$1.2B)

Arcus Biosciences, Inc.

RCUS|03969F109

Shares:31.4M

Value:$246.7M

% of Portfolio:20.9% ($246.7M/$1.2B)

ASSEMBLY BIOSCIENCES, INC.

ASMB|045396207

Shares:2.2M

Value:$21.1M

% of Portfolio:1.8% ($21.1M/$1.2B)

Merus N.V.

MRUS|N5749R100

Shares:452.5K

Value:$19.0M

% of Portfolio:1.6% ($19.0M/$1.2B)

Kyverna Therapeutics, Inc.

KYTX|501976104

Shares:4.1M

Value:$8.0M

% of Portfolio:0.7% ($8.0M/$1.2B)

Tango Therapeutics, Inc.

TNGX|87583X109

Shares:4.9M

Value:$6.7M

% of Portfolio:0.6% ($6.7M/$1.2B)

Xilio Therapeutics, Inc.

XLO|98422T100

Shares:9.1M

Value:$6.6M

% of Portfolio:0.6% ($6.6M/$1.2B)

Kalaris Therapeutics, Inc.

KLRS|482929106

Shares:723.3K

Value:$5.8M

% of Portfolio:0.5% ($5.8M/$1.2B)

HOOKIPA Pharma Inc.

HOOK|43906K209

Shares:1.9M

Value:$2.0M

% of Portfolio:0.2% ($2.0M/$1.2B)

Allogene Therapeutics, Inc.

ALLO|019770106

Shares:1.2M

Value:$1.7M

% of Portfolio:0.1% ($1.7M/$1.2B)

LEAP THERAPEUTICS, INC.

LPTX|52187K200

Shares:5.3M

Value:$1.6M

% of Portfolio:0.1% ($1.6M/$1.2B)

Ikena Oncology, Inc.

IKNA|45175G108

Shares:1.2M

Value:$1.5M

% of Portfolio:0.1% ($1.5M/$1.2B)

Barinthus Biotherapeutics plc.

BRNS|91864C107

Shares:369.9K

Value:$359.8K

% of Portfolio:0.0% ($359.8K/$1.2B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Arcellx, Inc.(ACLXcusip03940C100)	6.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$440.9M	37.3% ($440.9M/$1.2B)	QoQ -14.46% (-$74.5M) YoY-
GALAPAGOS NV(GLPGcusip36315X101)	16.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$419.4M	35.5% ($419.4M/$1.2B)	QoQ -9.16% (-$42.3M) YoY-
Arcus Biosciences, Inc.(RCUScusip03969F109)	31.4M	QoQ +4.53% (-1.4M) YoY-	All Managers (Combined)	$246.7M	20.9% ($246.7M/$1.2B)	QoQ -44.88% (-$200.9M) YoY-
ASSEMBLY BIOSCIENCES, INC.(ASMBcusip045396207)	2.2M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$21.1M	1.8% ($21.1M/$1.2B)	QoQ -39.41% (-$13.7M) YoY-
Merus N.V.(MRUScusipN5749R100)	452.5K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$19.0M	1.6% ($19.0M/$1.2B)	QoQ +0.09% (+$18.1K) YoY-
Kyverna Therapeutics, Inc.(KYTXcusip501976104)	4.1M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$8.0M	0.7% ($8.0M/$1.2B)	QoQ -48.39% (-$7.5M) YoY-
Tango Therapeutics, Inc.(TNGXcusip87583X109)	4.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$6.7M	0.6% ($6.7M/$1.2B)	QoQ -55.66% (-$8.3M) YoY-
Xilio Therapeutics, Inc.(XLOcusip98422T100)	9.1M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$6.6M	0.6% ($6.6M/$1.2B)	QoQ -24.14% (-$2.1M) YoY-
Kalaris Therapeutics, Inc.(KLRScusip482929106)	723.3K	QoQ NEW(+723.3K) YoY-	All Managers (Combined)	$5.8M	0.5% ($5.8M/$1.2B)	QoQ NEW(+$5.8M) YoY-
HOOKIPA Pharma Inc.(HOOKcusip43906K209)	1.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$2.0M	0.2% ($2.0M/$1.2B)	QoQ -46.26% (-$1.7M) YoY-
Allogene Therapeutics, Inc.(ALLOcusip019770106)	1.2M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.7M	0.1% ($1.7M/$1.2B)	QoQ -31.45% (-$775.0K) YoY-
LEAP THERAPEUTICS, INC.(LPTXcusip52187K200)	5.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.6M	0.1% ($1.6M/$1.2B)	QoQ -89.38% (-$13.7M) YoY-
Ikena Oncology, Inc.(IKNAcusip45175G108)	1.2M	QoQ -42.28% (-849.2K) YoY-	All Managers (Combined)	$1.5M	0.1% ($1.5M/$1.2B)	QoQ -54.95% (-$1.8M) YoY-
Barinthus Biotherapeutics plc.(BRNScusip91864C107)	369.9K	QoQ -40.37% (-250.5K) YoY-	All Managers (Combined)	$359.8K	0.0% ($359.8K/$1.2B)	QoQ -51.99% (-$389.6K) YoY-